Novel anti-inflammatory agents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/47 (2006.01) A61K 31/4375 (2006.01) A61K 31/472 (2006.01) A61K 31/517 (2006.01) A61K 31/519 (2006.01) A61P 9/00 (2006.01) A61P 29/00 (2006.01) C07D 239/91 (2006.01)

Patent

CA 2759241

Disclosed are methods of regulating interleukin-6 (IL-6) and/or vascular cell adhesion molecule-1 (VCAM-1) and methods of treating and/or preventing cardiovascular and inflammatory diseases and related disease states, such as, for example, atherosclerosis, asthma, arthritis, cancer, multiple sclerosis, psoriasis, and inflammatory bowel diseases, and autoimmune disease(s) by administering a naturally occurring or synthetic quinazolone derivative. The invention provides novel synthetic quinazolone compounds, as well as pharmaceutical compositions comprising those compounds.

L'invention porte sur des procédés de régulation de l'interleukine-6 (IL-6) et/ou de la molécule d'adhésion aux cellules vasculaires 1 (VCAM-1) et sur des procédés de traitement et/ou de prévention de maladies cardiovasculaires et inflammatoires et d'états de maladie apparentée, tels que par exemple l'athérosclérose, l'asthme, l'arthrite, le cancer, la sclérose en plaques, le psoriasis et des maladies intestinales inflammatoires et des maladies auto-immunes par l'administration d'un dérivé de quinazolone d'origine naturelle ou synthétique. L'invention porte sur de nouveaux composés quinazolone synthétiques ainsi que sur des compositions pharmaceutiques comprenant ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel anti-inflammatory agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1636222

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.